Investment Advisory Committee Member

Dr. Carl O. Pabo’s research in biophysics made him a world leader in issues involving the structure and design of DNA-binding proteins. Dr. Pabo was a Professor at the Johns Hopkins University School of Medicine (1982-1991) and at the Massachusetts Institute of Technology (1991-2001), and an investigator with the Howard Hughes Medical Institute (1986-2001). He was Chief Scientific Officer at Sangamo BioSciences from 2001-2003. More recently, Dr. Pabo’s work has focused on “long-range strategic thinking,” developing fresh ways of addressing some of the most pressing technical and social challenges of the modern age. While working on these projects, he has held appointments as a Visiting Professor at Caltech, Stanford, Berkeley, and Harvard; and has been supported by a Guggenheim Fellowship. He is a member of the US National Academy of Sciences and of the American Academy of Arts and Sciences.

He received his B.S. in Biochemistry and Biophysics from Yale in 1974 and received his Ph.D. in Biochemistry from Harvard in 1980.